相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis
J. Sieper et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Safety issues and concerns of new immunomodulators in rheumatology
Carlo Selmi et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
R. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Maxime Dougados et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
I-H Song et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Golimumab, a New Human Tumor Necrosis Factor α Antibody, Administered Every Four Weeks as a Subcutaneous Injection in Psoriatic Arthritis Twenty-Four-Week Efficacy and Safety Results of a Randomized, Placebo-Controlled Study
Arthur Kavanaugh et al.
ARTHRITIS AND RHEUMATISM (2009)
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
Martin Rudwaleit et al.
JOURNAL OF RHEUMATOLOGY (2009)
Golimumab inpatients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Josef S. Smolen et al.
LANCET (2009)
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis
Hildrun Haibel et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Robert D. Inman et al.
ARTHRITIS AND RHEUMATISM (2008)
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies
Jane Freeston et al.
JOINT BONE SPINE (2007)
Spondyloarthritis research consortium of Canada magnetic resonance Imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis
WP Maksymowych et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis -: A randomized clinical trial
A Wanders et al.
ARTHRITIS AND RHEUMATISM (2005)
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis - Results of a fifty-two-week, randomized, controlled study
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
M Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
How to diagnose axial spondyloarthritis early
M Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
分享论文
